...
首页> 外文期刊>Archives of cardiovascular diseases >Cardiac multislice computed tomography after transcatheter aortic valve implantation: Features after 'valve-in-valve' implantation for degenerative stented aortic bioprosthesis
【24h】

Cardiac multislice computed tomography after transcatheter aortic valve implantation: Features after 'valve-in-valve' implantation for degenerative stented aortic bioprosthesis

机译:经导管主动脉瓣植入后的心脏多层计算机断层扫描:变性瓣膜主动脉生物假体植入“瓣膜中”后的特征

获取原文
获取原文并翻译 | 示例
           

摘要

An 86-year-old woman complained of gradually increasing dyspnoea (New York Heart Association stage III). Ten years previously she had surgical aortic valve replacement with a stented bioprosthesis (21 mm Carpentier-Edwards; Edwards Lifesciences, Irvine, CA, USA) for severe symptomatic aortic stenosis. At the same time, a triple coronary bypass graft was performed. Five years after surgery, a permanent pacemaker was implanted. Follow-up transthoracic echocardiography demonstrated severe stenosis of the aortic bioprosthesis (maximal pressure gradient 80mmHg; aortic valve area 0.6 cm~2). Surgery was contraindicated (logistic EuroSCORE greater than 20%). The patient was referred to our centre for transcatheter aortic valve implantation (TAVT). Preimplantation multislice computed tomography (MSCT)-angiography confirmed the feasibility of the transfemoral approach, then a 23 mm Edwards SAPIEN XT bioprosthesis (Edwards Lifesciences) was successfully implanted from a right trans-femoral approach. Immediate follow-up was unremarkable with no significant aortic regurgitation. Cardiac CT angiography (HD750 Discovery; General Electric, Milwaukee, USA) was performed 5 days after TAVI to evaluate the SAPIEN XT bioprosthesis positioning and deployment into the underlying Carpentier-Edwards bioprosthesis. The Edwards-SAPIEN XT biopros-thesis was precisely implanted at the basal level of the degenerative bioprosthesis (Fig. 1A and B). Circularity was good but, as expected, expansion of the SAPIEN XT was sub-optimal at the basal level due to the 19 mm underlying stent (diameter 18.5x18.1 mm, measured surface 2.67cm~2, expected surface 4.15cm~2) (Fig. 1C and D). By comparison, on the aortic side of the SAPIEN bioprosthesis, expansion was optimal (Fig. 1E and F; diameter 23.7x22.5mm, measured surface 4.19cm2). Three-dimensional volume-rendering reconstructions accurately demonstrated the close link between the two stents (Fig. 1G and H).
机译:一名86岁妇女抱怨呼吸困难逐渐加重(纽约心脏协会第三阶段)。十年前,她因严重的症状性主动脉瓣狭窄而用带支架的生物假体(21毫米Carpentier-Edwards;爱德华兹生命科学公司,爱尔文,加利福尼亚州,美国)进行了主动脉瓣置换手术。同时,进行了三次冠状动脉搭桥术。手术五年后,植入了永久性起搏器。随访经胸超声心动图显示主动脉生物瓣膜严重狭窄(最大压力梯度为80mmHg;主动脉瓣面积为0.6 cm〜2)。禁止手术(后勤EuroSCORE大于20%)。该患者被转介到我们的经导管主动脉瓣植入术中心(TAVT)。植入前多层计算机断层扫描(MSCT)-血管造影证实了经股动脉入路的可行性,然后通过正确的经股动脉入路成功植入了23毫米的Edwards SAPIEN XT生物假体(Edwards Lifesciences)。没有明显的主动脉瓣关闭不全的立即随访。 TAVI后5天进行了心脏CT血管造影(HD750 Discovery;美国通用电气,密尔沃基),以评估SAPIEN XT生物假体的定位和在基础Carpentier-Edwards生物假体中的部署。 Edwards-SAPIEN XT生物假体正好植入了退化性生物假体的基础水平(图1A和B)。圆形度很好,但正如预期的那样,由于下方的19毫米支架(直径18.5x18.1毫米,测量表面2.67cm〜2,预期表面4.15cm〜2),SAPIEN XT的扩展在基底水平上不是最佳的(图1C和D)。相比之下,在SAPIEN生物假体的主动脉侧,扩张是最佳的(图1E和F;直径23.7x22.5mm,测量表面4.19cm2)。三维体积渲染重建准确地显示了两个支架之间的紧密联系(图1G和H)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号